GLYC

GlycoMimetics (GLYC)

About GlycoMimetics (GLYC)

GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.

Details

Daily high
$0.27
Daily low
$0.26
Price at open
$0.27
52 Week High
$3.18
52 Week Low
$0.14
Market cap
16.8M
Dividend yield
0.00%
Volume
2,766
Avg. volume
3.9M
P/E ratio
-.44

GlycoMimetics News

Details

Daily high
$0.27
Daily low
$0.26
Price at open
$0.27
52 Week High
$3.18
52 Week Low
$0.14
Market cap
16.8M
Dividend yield
0.00%
Volume
2,766
Avg. volume
3.9M
P/E ratio
-.44